SEC
SlamSEC
SearchBrowseEarnings

Sarepta Therapeutics, Inc.

Nasdaq:SRPT
Pharmaceutical Preparations·CAMBRIDGE, MA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(1000 total)

TypeDateAccessionPeriodSize
4
Mar 3, 2026
0001193125-26-0894394
Mar 2, 2026
4.7 KB
4
Mar 3, 2026
0001193125-26-0894334
Mar 2, 2026
4.8 KB
4
Mar 3, 2026
0001193125-26-0894324
Mar 1, 2026
10.1 KB
4
Mar 3, 2026
0001193125-26-0894254
Mar 1, 2026
10.1 KB
4
Mar 2, 2026
0001193125-26-0842654
Feb 26, 2026
10.1 KB
10-K
Mar 2, 2026
0001193125-26-08414410-K
Dec 31, 2025
27.4 MB
4
Feb 27, 2026
0001193125-26-0836744
Feb 25, 2026
5.7 KB
4
Feb 27, 2026
0001193125-26-0836714
Feb 25, 2026
5.7 KB
8-K
Feb 25, 2026
0001193125-26-0720648-K
Feb 25, 2026
140.1 KB
8-K
Feb 25, 2026
0001193125-26-0715668-K
Feb 25, 2026
1.1 MB
SCHEDULE 13G
Feb 13, 2026
0001167557-26-000049
—
8.8 KB
13F-HR
Feb 13, 2026
0001193125-26-049427
Dec 31, 2025
4.2 KB
4
Jan 29, 2026
0001193125-26-0298954
Jan 29, 2026
8.1 KB
4
Jan 29, 2026
0001193125-26-0298934
Jan 27, 2026
8.8 KB
SCHEDULE 13G/A
Jan 21, 2026
0002012383-26-000787
—
11.0 KB
8-K
Jan 12, 2026
0001193125-26-0101168-K
Jan 12, 2026
229.0 KB
4
Dec 19, 2025
0001193125-25-3269804
Dec 18, 2025
9.4 KB
8-K
Dec 19, 2025
0001193125-25-3269698-K
Dec 18, 2025
185.6 KB
4
Dec 18, 2025
0001193125-25-3253834
Dec 16, 2025
5.3 KB
144
Dec 16, 2025
0001950047-25-010429
—
4.8 KB
8-K
Dec 11, 2025
0001193125-25-3150328-K
Dec 10, 2025
162.9 KB
4
Dec 10, 2025
0001193125-25-3146524
Dec 1, 2025
6.3 KB
4
Dec 9, 2025
0001193125-25-3131844
Dec 7, 2025
11.4 KB
8-K
Dec 8, 2025
0001193125-25-3105888-K
Dec 7, 2025
240.5 KB
4
Dec 2, 2025
0001193125-25-3056624
Nov 28, 2025
4.7 KB
25 filings shown

Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States.